Cargando…

Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB to alleviate LPS-induced ALI

ETHNOPHARMACOLOGICAL RELEVANCE: Shufeng Jiedu capsule (SFJDC) is a pure form of traditional Chinese medicine (TCM) that contains eight medicinal plants. Known for its anti-inflammatory and antipyretic effects, it is mostly used to treat upper respiratory tract infections and other infectious disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Junnan, Wang, Yu-lian, Sheng, Xiao-dong, Zhang, Lei, Lv, Xiongwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392900/ https://www.ncbi.nlm.nih.gov/pubmed/36002086 http://dx.doi.org/10.1016/j.jep.2022.115661

Ejemplares similares

Study on basic and clinical application of Shufeng Jiedu Capsule in treating respiratory tract infection
por: Han, Yanqi, et al.
Publicado: (2023)

Analysis of the mechanism of Shufeng Jiedu capsule prevention and treatment for COVID-19 by network pharmacology tools
por: Xiong, Haijun, et al.
Publicado: (2020)

The add-on effect of Shufeng Jiedu capsule for treating COVID-19: A systematic review and meta-analysis
por: Sheng, Xiaodi, et al.
Publicado: (2022)

Efficacy and safety of Shufeng Jiedu capsule in the treatment of COVID-19: A protocol for systematic review and meta analysis
por: Ma, Li, et al.
Publicado: (2020)

Shufeng Jiedu capsules for treating acute exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Xia, Ru-yu, et al.
Publicado: (2020)

Analysis of the active components and mechanism of Shufeng Jiedu capsule against COVID-19 based on network pharmacology and molecular docking
por: Simayi, Jimilihan, et al.
Publicado: (2022)

Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology
por: Chen, Xiao, et al.
Publicado: (2020)

Efficacy and safety of Shufeng Jiedu capsule for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta-analysis
por: Li, Runmin, et al.
Publicado: (2020)

Chinese patent herbal medicine (Shufeng Jiedu capsule) for acute upper respiratory tract infections: A systematic review and meta-analysis
por: Zhang, Ying-ying, et al.
Publicado: (2021)

Efficacy and safety of Shufeng Jiedu Capsule in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis
por: Ren, Huijun, et al.
Publicado: (2021)

Shufeng Jiedu capsule for acute exacerbation of chronic obstructive pulmonary disease: a protocol of multicentre, randomised, double-blind, placebo-controlled trial
por: Xia, Ruyu, et al.
Publicado: (2023)

Chinese Patent Medicine Shufeng Jiedu Capsules as an Adjuvant Therapy for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

Systematic analyses on the potential immune and anti-inflammatory mechanisms of Shufeng Jiedu Capsule against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-caused pneumonia
por: Tao, Zhengang, et al.
Publicado: (2020)

Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study
por: XIA, Lu, et al.
Publicado: (2021)

Xuanfei Baidu formula alleviates impaired mitochondrial dynamics and activated NLRP3 inflammasome by repressing NF-κB and MAPK pathways in LPS-induced ALI and inflammation models
por: Li, Zhenhao, et al.
Publicado: (2023)

BHBA Suppresses LPS-Induced Inflammation in BV-2 Cells by Inhibiting NF-κB Activation
por: Fu, Shou-Peng, et al.
Publicado: (2014)

Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-κB Axis
por: Qu, Yifan, et al.
Publicado: (2021)

Tacrolimus alleviates LPS‐induced AKI by inhibiting TLR4/MyD88/NF‐κB signalling in mice
por: Hu, Xueqing, et al.
Publicado: (2021)

Renoprotective effects of Gushen Jiedu capsule on diabetic nephropathy in rats
por: Zhang, Lei, et al.
Publicado: (2020)

Inhibition of TRPV4 attenuates ferroptosis against LPS-induced ALI via Ca(2+) pathway
por: CAI, Junying, et al.
Publicado: (2022)

Xanthatin Alleviates LPS-Induced Inflammatory Response in RAW264.7 Macrophages by Inhibiting NF-κB, MAPK and STATs Activation
por: Liu, Yuanqi, et al.
Publicado: (2022)

UFL1 Alleviates LPS-Induced Apoptosis by Regulating the NF-κB Signaling Pathway in Bovine Ovarian Granulosa Cells
por: Wang, Xinling, et al.
Publicado: (2020)

Chinese Herb Jiedu Huayu Granules Inhibiting Immune and Inflammatory Response of Rats with Acute Liver Failure by Regulating the NF-κB Signaling Pathway
por: Bai, Wenjie, et al.
Publicado: (2022)

Aspirin inhibits LPS-induced macrophage activation via the NF-κB pathway
por: Liu, Yitong, et al.
Publicado: (2017)

Case report: ‘AARS2 leukodystrophy’
por: Axelsen, Tobias Melton, et al.
Publicado: (2021)

Silymarin Inhibits Morphological Changes in LPS-Stimulated Macrophages by Blocking NF-κB Pathway
por: Kim, Eun Jeong, et al.
Publicado: (2015)

NF-κB inhibition attenuates LPS-induced TLR4 activation in monocyte cells
por: Wan, Jian, et al.
Publicado: (2016)

Fengshi Gutong Capsule Attenuates Osteoarthritis by Inhibiting MAPK, NF-κB, AP-1, and Akt Pathways
por: Gao, Yao-Xin, et al.
Publicado: (2018)

Lactobacillus plantarum L15 Alleviates Colitis by Inhibiting LPS-Mediated NF-κB Activation and Ameliorates DSS-Induced Gut Microbiota Dysbiosis
por: Yu, Peng, et al.
Publicado: (2020)

The regulatory effect of flavonoids extracted from Abutilon theophrasti leaves on gene expression in LPS-induced ALI mice via the NF-κB and MAPK signaling pathways
por: Tian, Chunlian, et al.
Publicado: (2019)

(-)-α-Bisabolol Alleviates Atopic Dermatitis by Inhibiting MAPK and NF-κB Signaling in Mast Cell
por: Li, Guangxia, et al.
Publicado: (2022)

β-Sitosterol Alleviates Inflammatory Response via Inhibiting the Activation of ERK/p38 and NF-κB Pathways in LPS-Exposed BV2 Cells
por: Sun, Yanan, et al.
Publicado: (2020)

Metformin Alleviates LPS-Induced Acute Lung Injury by Regulating the SIRT1/NF-κB/NLRP3 Pathway and Inhibiting Endothelial Cell Pyroptosis
por: Zhang, Yunqian, et al.
Publicado: (2022)

Astragaloside IV Inhibits NF-κB Activation and Inflammatory Gene Expression in LPS-Treated Mice
por: Zhang, Wei-Jian, et al.
Publicado: (2015)

The gut microbiota metabolite urolithin A inhibits NF-κB activation in LPS stimulated BMDMs
por: Abdelazeem, Khalid N. M., et al.
Publicado: (2021)

Anti-inflammation of isoliquiritigenin via the inhibition of NF-κB and MAPK in LPS-stimulated MAC-T cells
por: Li, Manman, et al.
Publicado: (2022)

AKR1C1 alleviates LPS-induced ALI in mice by activating the JAK2/STAT3 signaling pathway
por: Wang, Xianjun, et al.
Publicado: (2021)

Zhuifeng tougu capsules inhibit the TLR4/MyD88/NF-κB signaling pathway and alleviate knee osteoarthritis: In vitro and in vivo experiments
por: Xu, Xiaotong, et al.
Publicado: (2022)

Gypenosides Inhibit Inflammatory Response and Apoptosis of Endothelial and Epithelial Cells in LPS-Induced ALI: A Study Based on Bioinformatic Analysis and in vivo/vitro Experiments
por: Tu, Qing, et al.
Publicado: (2021)

TREM-1 promoted apoptosis and inhibited autophagy in LPS-treated HK-2 cells through the NF-κB pathway
por: Pan, Pan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3ub5ocpnjjnn0alo4em3lqjl9r